Market Overview

Research and Markets: Global Psoriatic Arthritis Epidemiology and Patient Flow Analysis - 2012


Research and Markets ( has announced the addition of the "Global Psoriatic Arthritis Epidemiology and Patient Flow Analysis - 2012" report to their offering.

Fore Pharma announced the results of its Psoriatic Arthritis patient population study in a new report Global Psoriatic Arthritis Epidemiology and Patient Flow Analysis - 2012'. The report provides insights into Psoriatic Arthritis epidemiology, Psoriatic Arthritis diagnosed patients, and Psoriatic Arthritis treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Psoriatic Arthritis derived from epidemiological analysis, percentage of patients diagnosed with Psoriatic Arthritis, and percentage of patients treated with Psoriatic Arthritis therapy.

The study helps executives estimate Psoriatic Arthritis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Psoriatic Arthritis prevalence, Psoriatic Arthritis diagnosis rate, and Psoriatic Arthritis treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:

- Psoriatic Arthritis: Disease Definition

- Psoriatic Arthritis Patient Flow

- Psoriatic Arthritis Prevalence

- Psoriatic Arthritis Diagnosed Patients

- Psoriatic Arthritis Treated Patients

For more information visit

Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

View Comments and Join the Discussion!

Partner Center